TWO ABSTRACTS AT AACR CONFERENCE PRESENT DETAILED STUDY DESIGN AND INNOVATIVE BIOMARKER STRATEGY FOR ONGOING PHASE I STUDY OF EVT801 IN ADVANCED CANCER
SYDNEY, April 8, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), a late stage, oncology-focused drug development company, is pleased to announce two presentations detailing the ongoing phase I study of the company's investigational novel drug, EVT801, a selective VEGFR3 inhibitor with potential application in a variety of cancers. The...
Snorkel AI Raises $350 Million to Help Push the Frontier: NYSE Content Update
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Oct. 7, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Jake...
Shengfeng Development Limited Announces First Half of Fiscal Year 2023 Unaudited Financial Results
Revenue up 11.1% Year Over Year Net Income up 163.3% Year Over Year FUZHOU, China, Oct. 12, 2023 /PRNewswire/ -- Shengfeng Development Limited (the "Company" or "Shengfeng"), a contract logistics company in China providing customers with integrated logistics solution services, announced today its unaudited interim financial results for the six months ended June 30, 2023. Financial highlights for the...
Atomicwork and Lansweeper Announce Integration to Bring Universal Context and Asset Intelligence to Enterprise IT
SAN FRANCISCO, Nov. 6, 2025 /PRNewswire/ -- Atomicwork, the leading AI-native ITSM solution for modern enterprises, today announced a strategic partnership with Lansweeper, the global leader in IT asset discovery and configuration intelligence. Atomicwork integrates with Lansweeper The partnership brings Lansweeper's real-time asset discovery into Atomicwork's agentic service management platform, giving enterprises complete...
MUSEUM OF ISLAMIC ART PRESENTS LANDMARK EXHIBITION SURVEYING THE ISLAMIC ARTISTIC TRADITIONS OF MOROCCO
DOHA, Qatar, Nov. 5, 2024 /PRNewswire/ --The Museum of Islamic Art (MIA) unveiled Splendours of the Atlas: A Voyage Through Morocco's Heritage, on view until 8 March 2025. Organized as part of the Qatar-Morocco 2024 Year of Culture, the exhibition presents around 200 objects to tell a multifaceted story of Moroccan history, society, artistic expressions, and how they continue...
TONIK PARTNERS WITH XENDIT TO EXTEND PAYMENT OPTIONS
MANILA, Philippines, Feb. 13, 2024 /PRNewswire/ -- Tonik Digital Bank (Tonik) announces its newest strategic collaboration with prominent Southeast Asian payment gateway, Xendit. The partnership marks a significant milestone for both companies, as they join forces to deliver secure, convenient, and customer-centric financial solutions. Tonik partners with Xendit to extend payment options The partnership with Xendit...
vivo and UNESCO Partner to Launch the “Capture the Future” Initiative in Asia
Empowering the next generation of visual storytellers. BANGKOK, March 4, 2025 /PRNewswire/ -- vivo has officially launched the "Capture the Future" initiative in Thailand, in partnership with UNESCO. The initiative, announced at the Crystal Box, Gaysorn Urban Resort, aims to foster youth creativity by encouraging students to explore the essential topics of science, education and society through the art of...
Therakos Receives MDR Approval in Europe for Treating Immune-Related Adverse Events in Patients with Inadequate Response to Corticosteroids
DUBLIN, Oct. 22, 2026 /PRNewswire/ -- Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal photopheresis (ECP), announced today that its THERAKOS™ CELLEX™ Photopheresis System has received certification under the EU MDR for an expanded indication. The system is now indicated in Europe for the treatment...
CARsgen Announced 2024 Annual Results
SHANGHAI, March 19, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced its 2024 Annual Results. Business Highlights Zevor-cel was approved by China's National Medical Products Administration (NMPA). As of December 31, 2024, certification and filings for zevor-cel completed in 23...
CPIC Life (H.K.) Assigned by Moody’s An A3 IFSR, Outlook Stable
HONG KONG, Oct. 22, 2023 /PRNewswire/ -- China Pacific Life Insurance (H.K.) Company Limited ("CPIC Life (HK)" or "the Company") is pleased to announce that the Company was assigned by Moody's Investors Service (Moody's), an A3 Insurance Financial Strength Rating (IFSR) with a stable outlook. This is the first time that Moody's has assigned a rating to CPIC Life (HK). The A3...








